Kazunori Soma

Title: Kazunori Soma: Innovator in Agglutination Immunoassay Technology

Introduction

Kazunori Soma is a notable inventor based in Tokorozawa, Japan. He has made significant contributions to the field of immunoassay technology, particularly through his innovative methods and apparatuses. With a total of 2 patents to his name, Soma's work has the potential to enhance diagnostic processes in various medical applications.

Latest Patents

Kazunori Soma's latest patents focus on a method and apparatus for agglutination immunoassay. This innovative approach involves several key steps. First, a test sample suspected of containing a desired analyte is contacted with a reagent that includes sensitized magnetic-material containing particles. These particles are capable of reacting with and binding to the desired analyte. The next step involves precipitating the particles at the bottom of a container using magnetic force. The container is then inclined to allow the particles to flow along the bottom, forming a developed pattern. An imaging device is used to obtain a representative length of this pattern. Finally, the presence or absence of an immune reaction is detected based on the representative length of the pattern, enabling the identification of the desired analyte in the test sample.

Career Highlights

Kazunori Soma is currently employed at Fujirebio Inc., a company known for its advancements in diagnostic technologies. His work at Fujirebio has allowed him to focus on developing innovative solutions that can improve the accuracy and efficiency of immunoassays.

Collaborations

Soma has collaborated with notable colleagues in his field, including Yoshihiro Kinoshita and Tomoo Saito. These collaborations have likely contributed to the refinement and success of his innovative projects.

Conclusion

Kazunori Soma's contributions to agglutination immunoassay technology exemplify the impact of innovation in the medical field. His patents reflect a commitment to enhancing diagnostic methods, which can lead to better healthcare outcomes.